Skip to main content

Dr. Rose’s clinical interest is in the treatment of patients with genitourinary cancers, including bladder, kidney, prostate, and testicular cancers. She has a focus on the development of novel therapies and combination therapies for patients with urologic malignancies, including the design and implementation of clinical trials. She also studies the molecular alterations that contribute to the development of genitourinary cancers. She is pod leader of the genitourinary oncology group within the Clinical Protocol Office with a focus on non-prostate GU studies.


UNC AFFILIATIONS:

(DOM) Oncology, Department of Medicine (DOM), Lineberger Cancer Center

CLINICAL/RESEARCH INTERESTS:

Clinical Trials, Prostate Cancer, Translational Medicine